What is the address of Dr. COOREMAN Gilbert, gynaecoloog?

The registered office of Dr. COOREMAN Gilbert, gynaecoloog is located at Blighbankhelling(Odk) 3, 8670 Koksijde.

Is Dr. COOREMAN Gilbert, gynaecoloog still active?

Yes. According to the CBE (17 September 2026) Dr. COOREMAN Gilbert, gynaecoloog is active, legal situation “Normale toestand”, started on 2 February 1988.

Is Dr. COOREMAN Gilbert, gynaecoloog registered on Peppol?

No, Dr. COOREMAN Gilbert, gynaecoloog is currently not registered on the Peppol network.

What is the enterprise number of Dr. COOREMAN Gilbert, gynaecoloog?

The enterprise number of Dr. COOREMAN Gilbert, gynaecoloog is BE0433263267.

When was Dr. COOREMAN Gilbert, gynaecoloog founded?

Dr. COOREMAN Gilbert, gynaecoloog was founded on 2 February 1988.

Who are the directors of Dr. COOREMAN Gilbert, gynaecoloog?

According to the 2025 annual accounts, the directors of Dr. COOREMAN Gilbert, gynaecoloog are: GILBERT COOREMAN.

Is Dr. COOREMAN Gilbert, gynaecoloog a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 2 February 1988; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. COOREMAN Gilbert, gynaecoloog make in 2025?

Dr. COOREMAN Gilbert, gynaecoloog recorded a loss after taxes of € 17,544 in financial year 2025.

What is the revenue of Dr. COOREMAN Gilbert, gynaecoloog?

As a small company, Dr. COOREMAN Gilbert, gynaecoloog is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -12,416.

Dr. COOREMAN Gilbert, gynaecoloog (Private Limited)

Dossier Dr. COOREMAN Gilbert, gynaecoloog, printed on 17 September 2026 from databakkes.be/en/0433263267/dr-cooreman-gilbert-gynaecoloog. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Two loss years in a row NBB

Negative result in 2024 and 2025.
Tight liquidity NBB

Cash and receivables cover 45 % of short-term debt in 2025; threshold 65 %.
Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

Dr. COOREMAN Gilbert, gynaecoloog from Koksijde, company number BE0433263267, closed financial year 2025 with a result of € -17,544 after tax. For that financial year Dr. COOREMAN Gilbert, gynaecoloog recorded a gross margin of € -12,416 and equity of € 25,607. Compared with financial year 2024, the result moved from € -16,949 to € -17,544. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 27, 2026.

What it is worth Healthy

€ 25,607

▼ 41% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -17,544

▼ 4 % more loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 15,668

▲ 39% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 13,210.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Taxes

€ 739

▲ 103% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ -4,240 Gross margin 2022: € -4,240 First fiscal year in the series	€ -9,418 Gross margin 2023: € -9,418 ▼ € 5,177 vs 2022 (€ -4,240) Unfavourable step	€ -7,370 Gross margin 2024: € -7,370 ▲ € 2,047 vs 2023 (€ -9,418) Favourable step	€ -12,416 Gross margin 2025: € -12,416 ▼ € 5,045 vs 2024 (€ -7,370) Unfavourable step	▼ € 5,045
Profit after taxes	€ -4,955 Profit after taxes 2022: € -4,955 First fiscal year in the series	€ -11,500 Profit after taxes 2023: € -11,500 ▼ € 6,545 vs 2022 (€ -4,955) Unfavourable step	€ -16,949 Profit after taxes 2024: € -16,949 ▼ € 5,449 vs 2023 (€ -11,500) Unfavourable step	€ -17,544 Profit after taxes 2025: € -17,544 ▼ € 595 vs 2024 (€ -16,949) Unfavourable step	▼ € 595
Equity	€ 71,600 Equity 2022: € 71,600 First fiscal year in the series	€ 60,100 Equity 2023: € 60,100 ▼ 16% vs 2022 (€ 71,600) Unfavourable step	€ 43,151 Equity 2024: € 43,151 ▼ 28% vs 2023 (€ 60,100) Unfavourable step	€ 25,607 Equity 2025: € 25,607 ▼ 41% vs 2024 (€ 43,151) Unfavourable step	▼ 41%
Total debts	€ 632 Total debts 2022: € 632 First fiscal year in the series	€ 680 Total debts 2023: € 680 ▲ 8% vs 2022 (€ 632) Unfavourable step	€ 13,164 Total debts 2024: € 13,164 ▲ € 12,484 vs 2023 (€ 680) Unfavourable step	€ 34,865 Total debts 2025: € 34,865 ▲ 165% vs 2024 (€ 13,164) Unfavourable step	▲ 165%
Cash	€ 6,138 Cash 2022: € 6,138 First fiscal year in the series	€ 2,497 Cash 2023: € 2,497 ▼ 59% vs 2022 (€ 6,138) Unfavourable step	€ 11,234 Cash 2024: € 11,234 ▲ € 8,736 vs 2023 (€ 2,497) Favourable step	€ 15,668 Cash 2025: € 15,668 ▲ 39% vs 2024 (€ 11,234) Favourable step	▲ 39%
Land & buildings	€ 16,733 Land & buildings 2022: € 16,733 First fiscal year in the series	€ 16,733 Land & buildings 2023: € 16,733 Unchanged (€ 16,733) Unchanged	€ 16,733 Land & buildings 2024: € 16,733 Unchanged (€ 16,733) Unchanged	€ 16,733 Land & buildings 2025: € 16,733 Unchanged (€ 16,733) Unchanged
Retained profit	€ 59,203 Retained profit 2022: € 59,203 First fiscal year in the series	€ 47,703 Retained profit 2023: € 47,703 ▼ 19% vs 2022 (€ 59,203) Unfavourable step	€ 30,754 Retained profit 2024: € 30,754 ▼ 36% vs 2023 (€ 47,703) Unfavourable step	€ 13,210 Retained profit 2025: € 13,210 ▼ 57% vs 2024 (€ 30,754) Unfavourable step	▼ 57%
Balance sheet total	€ 72,232 Balance sheet total 2022: € 72,232 First fiscal year in the series	€ 60,780 Balance sheet total 2023: € 60,780 ▼ 16% vs 2022 (€ 72,232) Unchanged	€ 56,315 Balance sheet total 2024: € 56,315 ▼ 7% vs 2023 (€ 60,780) Unchanged	€ 60,472 Balance sheet total 2025: € 60,472 ▲ 7% vs 2024 (€ 56,315) Unchanged	▲ 7%

Key figures of Dr. COOREMAN Gilbert, gynaecoloog, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. COOREMAN Gilbert, gynaecoloog?

What happened at Dr. COOREMAN Gilbert, gynaecoloog in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 27, 2026 New annual accounts for financial year 2025: loss of € 17,544. Source: NBB ↗
Jun 14, 2008 New establishment in Aalst. KBO
Feb 2, 1988 Start of the company according to the CBE. KBO

In short

From € 4,955 loss in 2022 to € 17,544 loss in 2025.

Paid € 1,419 in corporate taxes since 2022.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. COOREMAN Gilbert, gynaecoloog? We notify you, reason included.

Follow Dr. COOREMAN Gilbert, gynaecoloog

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

GILBERT COOREMAN

Dr. COOREMAN Gilbert, gynaecoloog

Behind Dr. COOREMAN Gilbert, gynaecoloog is GILBERT COOREMAN.

See the full network in the app

Directors

According to the 2025 annual accounts

GILBERT COOREMAN

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Blighbankhelling(Odk) 3

8670 Koksijde

2.301.236.710

Baron Romain Moyersoen Park 17

9300 Aalst

Active since 14 June 2008

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0433.263.267
VAT number: BE 0433.263.267
Registered office: Blighbankhelling(Odk) 3, 8670 Koksijde
Names & denominations: Dr. COOREMAN Gilbert, gynaecoloog
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 2 February 1988
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗